BridgeMD
Compares treatment options for Urinary Bladder Neoplasms
Official title Early vs Delayed Intravesical Blad-Care During BCG Therapy
ClinicalTrials.gov ID: NCT07495072
What this study is testing
What is Hyaluronic Acid and Chondroitin Sulfate (Blad-Care™)?
Hyaluronic Acid and Chondroitin Sulfate (Blad-Care™) is an investigational medicine, being studied as a potential treatment for urinary bladder neoplasms.
Also referred to as Sodium Hyaluronate and Chondroitin Sulfate, Blad-Care.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Intravesical Bacillus Calmette-Guérin (BCG) therapy is the standard adjuvant treatment for patients with intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC). However, BCG therapy frequently induces local bladder irritation symptoms including urinary frequency, urgency, dysuria, hematuria, and suprapubic pain, which may reduce quality of life and lead to treatment interruption.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Adults aged ≥19 years
- Histologically confirmed non-muscle-invasive bladder cancer
- Candidates for intravesical BCG therapy
- Negative urine culture prior to BCG therapy
- Ability to provide written informed consent
You likely can't join if
- Hypersensitivity to components of Blad-Care
- Contraindication to BCG therapy
- Neurogenic bladder or significant urinary tract abnormalities
- Severe renal dysfunction
- Any condition considered unsuitable for study participation by the investigator
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Dongdaemun-gu, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Dongdaemun-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.